Individualization of long-term enzyme replacement therapy for Gaucher disease. - Wikidata - wikimedia - TriplyDB

Individualization of long-term enzyme replacement therapy for Gaucher disease.

Individualization of long-term enzyme replacement therapy for Gaucher disease.

http://www.wikidata.org/entity/Q33365037

about

Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders Clinical manifestations and management of Gaucher disease Imiglucerase and its use for the treatment of Gaucher's disease A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment The European Gaucher Alliance: a survey of member patient organisations' activities, healthcare environments and concerns.Progressive retinal degeneration and accumulation of autofluorescent lipopigments in Progranulin deficient mice.A reappraisal of Gaucher disease-diagnosis and disease management algorithms.Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1 Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships.Management of bone disease in Gaucher disease type 1: clinical practice.Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry.Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients.The history and accomplishments of the ICGG Gaucher registry.A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

P2860

Q26771677-BC10333A-1DDD-4CBD-84C0-F48E76BC4BDF Q26775747-3494D76A-7814-49DC-926E-AA9931A4AB21 Q28287175-A044CB42-6DDA-49B1-AC3B-923BFF9A2925 Q30235844-47FBE5BE-35FC-48E0-A0B9-92A5D850B3F2 Q33403298-28088B4B-66CC-4459-92AF-74F0239329E4 Q34151422-CC3D2B2A-907B-410E-832E-3DCDDE03811B Q34622488-2AC3527E-55D3-4163-A775-1D75B8137F16 Q34683786-1BB728F9-E0A1-4D5E-8D35-3990D0D50749 Q35615361-656CFC11-C119-474E-BB72-FB6766C70DF9 Q35754621-5D42DF48-268C-42F6-924D-E5A6ADEBFE1D Q36088711-B43C8F1A-8E10-4600-89FF-E6C04D05FC2B Q36456300-583927D9-AC96-446A-85A5-A66A30AE7579 Q37221766-317A4A91-81E5-4984-8B8C-3C9CBF8F91F0 Q37354438-7DBDCAAC-83E8-442C-A1F7-69FE137DD9A9 Q37413920-65A346A4-F9A8-44D6-9D97-1781C15567E4 Q37594794-B9D35421-07DC-4CD8-92FE-FA48C88B580E Q38290826-5D67A136-A547-4B91-8E97-782B7E111A27 Q38533848-D477A873-835F-4DCC-BD24-42122C19140B Q40649689-728F2A7A-738F-4C79-87C3-1D2E5691D637 Q41652308-E9C61B79-CB30-428D-AC4F-DC2B322E0B95 Q47143887-267DF6D7-3A66-48D3-969A-DE9E51A0F428

P2860

Individualization of long-term enzyme replacement therapy for Gaucher disease.

http://www.wikidata.org/entity/Q33365037

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@ast

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@en

type

label

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@ast

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@en

prefLabel

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@ast

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@en

P1433

Q33365037-B7483192-E776-4BBA-BB3D-10F101EF0EC0

P1476

Q33365037-A8BBCE7D-7CD9-44C5-B3C9-4C4208C0F586

P2093

Q33365037-01FBDBAE-E85C-4061-AD2F-8A170F59D366

Q33365037-232ABC77-9031-4494-9CA2-D422C38582B0

Q33365037-54D38C4C-9DA3-44FE-98B0-DFC49FE4E11A

Q33365037-69B410FA-945E-4AFA-BB4B-97A83ED082D0

Q33365037-7001AD3C-5E3D-41E8-ADB0-9055EEC6B6CF

Q33365037-8C896EED-EC9D-4DED-B331-0342E2ED8B58

Q33365037-A418C2E4-C7DB-4AAE-8DF0-88A6B70158E4

Q33365037-BC16F35D-7A14-4B27-9047-00704D4A4925

Q33365037-CC91ED54-428F-49DE-BF9A-E362426938AF

Q33365037-F353A119-40B4-48D6-95A3-A6F8356AB048

P2860

Q33365037-18B714AD-113F-4C0D-968E-FFE407C56150

Q33365037-238B9378-7E16-4AE2-8FC9-7E8D6DE9B019

Q33365037-36AD365D-89B2-49AA-8855-10375CED63F0

Q33365037-57DBCC41-5369-4A77-B3F7-ECBBB9FAAA43

Q33365037-5B608AB8-4521-48A8-B09A-9EA8F818EE8B

Q33365037-8B7BFB77-06A8-4919-A2ED-BE3E113FE361

Q33365037-914DC345-82B8-4E18-B535-C6BAD8232A2B

Q33365037-9CD757FB-D694-4AAE-9BBC-5972DE388EB4

Q33365037-B6879481-6D48-437D-9CDB-99D782FD57F2

Q33365037-D0D28691-5597-4924-832D-7DA7956AC64F

P2888

Q33365037-0C258CAF-537C-441A-B27C-8494668D8C98

P304

Q33365037-5A8DBAEF-92D5-41C2-8766-9C91EE61EC07

P31

Q33365037-6EAB1A8B-B407-4A24-AF58-582B8AC91788

P356

Q33365037-D019BBA9-B65C-4623-BD53-6403BFAED9A9

P407

Q33365037-5BC46AE3-9736-44FB-ADB3-15BACF071070

P433

Q33365037-592B125F-3A28-4DBC-896E-D079F50D99E7

P478

Q33365037-B92262D8-EA44-4F19-84B4-22920849E0F6

P577

Q33365037-93F890EF-0253-4FD8-975B-B90530656B49

P6179

Q33365037-B6DDAE83-FA3F-4971-8E6B-A9BFBCDDC942

P698

Q33365037-EF55C57F-9F56-45DC-8413-83F4F5D88BA6

P921

Q33365037-5FAB23A7-E385-4C99-885F-79C56A2BC9DB

P356

01.GIM.0000153660.88672.3C

P1433

Genetics in Medicine

P1476

Individualization of long-term enzyme replacement therapy for Gaucher disease.

@en

P2093

Ainu Prakash-Cheng

http://www.w3.org/2001/XMLSchema#string

Barry E Rosenbloom

http://www.w3.org/2001/XMLSchema#string

C Ronald Scott

http://www.w3.org/2001/XMLSchema#string

Gregory M Pastores

http://www.w3.org/2001/XMLSchema#string

Hans C Andersson

http://www.w3.org/2001/XMLSchema#string

International Collaborative Gaucher Group U.S. Regional Coordinators

http://www.w3.org/2001/XMLSchema#string

Joel Charrow

http://www.w3.org/2001/XMLSchema#string

Neal J Weinreb

http://www.w3.org/2001/XMLSchema#string

Paige Kaplan

http://www.w3.org/2001/XMLSchema#string

Pramod Mistry

http://www.w3.org/2001/XMLSchema#string

P2860

Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy.

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Therapeutic goals in the treatment of Gaucher disease.

Clinically relevant therapeutic endpoints in type I Gaucher disease.

Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1.

Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder.

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement.

Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume.

P2888

01.gim.0000153660.88672.3c

P304

105-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.GIM.0000153660.88672.3C

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027372857

http://www.w3.org/2001/XMLSchema#string

P698

15714077

http://www.w3.org/2001/XMLSchema#string

P921

Enzyme replacement therapy